Paracrine secretome

The paracrine secretome refers to the vast array of bioactive molecules—including proteins, lipids, and nucleic acids—secreted by cells into the extracellular space to influence the behavior of neighboring cells (Gnecchi et al., 2008, Circulation Research). Unlike traditional pharmacological agents that target a single, discrete molecular entity, the secretome functions as a multi-targeted therapeutic system, exerting its effects through the collective action of various cytokines and growth factors on multiple endogenous receptors (Teixeira et al., 2013, Journal of Controlled Release). This mechanism is a hallmark of regenerative medicine, particularly in mesenchymal stem cell (MSC) therapies, where the therapeutic benefit is increasingly attributed to these secreted factors rather than the direct differentiation of the cells themselves (Caplan & Correa, 2011, Cell Stem Cell). By modulating inflammatory pathways, promoting angiogenesis, and inhibiting apoptosis, the secretome plays a critical role in treating complex conditions such as myocardial infarction, chronic wounds, and graft-versus-host disease (Vizoso et al., 2017, International Journal of Molecular Sciences). However, the inherent complexity and variability of these biological mixtures present significant challenges for drug standardization, characterization, and regulatory approval compared to single-molecule therapeutics.

Other names

SecretomeParacrine factorsCellular secretomeConditioned mediaExtracellular vesiclesExosomesMSC-derived secretome

Broad paracrine signaling mediated by the simultaneous secretion of cytokines, chemokines, growth factors, and extracellular vesicles that activate multiple endogenous receptors to modulate the tissue microenvironment and promote regeneration.